No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease

Nucleosides, Nucleotides and Nucleic Acids

Volumn 25, Issue 9-11, 2006, Pages 1033-1037

  Lindqvist, M ^a   Hindorf, U ^b   Almer, S ^a   Soderkvist P ^a   Strom M ^a   Hjortswang, H ^a   Peterson, C ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Enzyme induction; Inflammatory bowel disease; Thiopurine methyltransferase; TPMT gene expression

Indexed keywords

6 MERCAPTOPURINE DERIVATIVE; AZATHIOPRINE; DRUG METABOLITE; MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ARTICLE; BODY WEIGHT; BONE MARROW TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; ENZYME ACTIVITY; ERYTHROCYTE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PATIENT COMPLIANCE; PHARMACOGENETICS; TREATMENT WITHDRAWAL; ULCERATIVE COLITIS;

6-MERCAPTOPURINE; ALLELES; ANTIMETABOLITES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; METHYLTRANSFERASES; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; PURINES; PYROPHOSPHATASES; TIME FACTORS;

EID: 33750459930     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770600890814     Document Type: Article

References (11)

1. Dubinsky, M.C.; Yang, H.; Hassard, P.V.; Seidman, E.G.; Kam, L.Y.; Abreu, M.T.; Targan, S.R.; Vasiliauskas, E.A. 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology 2002, 122, 904-915.
2. Lennard, L. The clinical pharmacology of 6-mercaptopurine. Eur. J. Clin. Pharmacol. 1992, 43, 329-339.
3. Lindqvist, M.; Almer, S.; Peterson, C.; Söderkvist, P. Real-time RT-PCR methodology for quantification of thiopurine methyltransferase gene expression. Eur. J. Clin. Pharmacol. 2003, 59, 207-211.
4. Pettersson, B.; Almer, S.; Albertioni, F.; Söderhall, S.; Peterson, C. Differences between children and adults in thiopurine methyltransferase activity and metabolite formation during thiopurine therapy: Possible role of concomitant methotrexate. Ther. Drug Monit. 2002, 24, 351-358.
5. Lindqvist, M.; Haglund, S.; Almer, S.; Peterson, C. Taipalensu, J.; Hertervig, E.; Lyrenas, E.; Söderkvist, P. Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics 2004, 14, 261-265.
6. Haglund, S.; Lindqvist, M.; Almer, S.; Peterson, C. Taipalensuu, J. Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin. Chem. 2004, 50, 288-295.
7. Marsh, S.; King, C.R.; Ahluwalia, R.; McLeod, H.L. Distribution of ITPA P32T alleles in multiple world populations. J. Hum. Genet. 2004, 49, 579-581.
8. Dervieux, T.; Blanco, J.G.; Krynetski, E.Y.; Vanin, E.F.; Roussel, M.F.; Relling, M.V. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells. Cancer Res. 2001, 61, 5810-5816.
9. Arenas, M.; Duley, J.A.; Ansari, A.; Shobowale-Bakre, E.A.; Fairbanks, L.; Soon, S.Y.; Sanderson, J.; Marinaki, A.M. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype. Nucleosides Nucleotides Nucleic Acids 2004, 23, 1403-1405.
10. Brouwer, C.; De Abreu, R.A.; Keizer-Garritsen, J.J.; Lambooy, L.H.; Ament, K.; ter Riet, P.G.; van Wering, E.R.; Trijbels, F.J.; Veerman, A.J.; Hoogerbrugge, P.M.; Bokkerink, J.P. Thiopurine methyltransferase in acute lymphoblastic leukaemia: biochemical and molecular biological aspects. Eur. J. Cancer 2005, 41, 613-623.
11. Gearry, R.B.; Roberts, R.L.; Barclay, M.L.; Kennedy, M.A. Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine. Pharmacogenetics 2004, 14, 779-781.